Michael A. Klobuchar - 30 Apr 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Reporting relationship
EVP - Chief Strategy Officer
Issuer ticker
MRK
Reported as of
30 Apr 2024
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 May 2024, 16:09:31 UTC
Prior SEC filing
16 Feb 2024
Next SEC filing
02 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kelly E. W. Grez, attorney-in-fact for Michael Klobuchar

Key filing fact

Michael A. Klobuchar filed Form 4 for Merck & Co., Inc. (MRK) on 02 May 2024.

Key facts

  • This page summarizes Michael A. Klobuchar's Form 4 filing for Merck & Co., Inc. (MRK).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 02 May 2024, 16:09.

Change

  • Previous filing in this sequence was filed on 16 Feb 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
23,171
Date
30 Apr 2024
Ownership
Direct
Footnotes
F1
MRK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6
Date
30 Apr 2024
Ownership
By Child
MRK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6
Date
30 Apr 2024
Ownership
By Child
MRK holding

Common Stock - 401(k) Plan

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
867
Date
30 Apr 2024
Ownership
By 401(k)
Footnotes
F2
MRK holding

Common Stock - 401(k) Plan

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
697
Date
30 Apr 2024
Ownership
By Spouse
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MRK transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+20,508
Change %
Price
$0.000000
Shares after
20,508
Date
30 Apr 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,508
Exercise price
$129.22
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Holdings include shares acquired in dividend reinvestment transactions.

Footnote F2

Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.

Footnote F3

The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .